Alpha Teknova, Inc. (TKNO)
NASDAQ: TKNO · IEX Real-Time Price · USD
6.10
+0.12 (2.01%)
Feb 7, 2023, 4:00 PM EST - Market closed
Alpha Teknova Market Cap
Alpha Teknova has a market cap or net worth of $171.60 million as of February 8, 2023. Alpha Teknova's market cap has decreased by -59.58% in one year.
Market Cap
171.60M
Enterprise Value
157.70M
1-Year Change
-59.58%
Ranking
Category
Stock Price
$6.10
Market Cap Chart
Since the IPO on June 25, 2021, Alpha Teknova, Inc.'s market cap has decreased from $433.79M to $171.60M, a decrease of -60.44%. That is a compound annual growth rate of -43.60%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 6, 2023 | 171.60M | -2.40% |
Feb 3, 2023 | 175.82M | 2.97% |
Feb 2, 2023 | 170.75M | 1.68% |
Feb 1, 2023 | 167.94M | 0.17% |
Jan 31, 2023 | 167.66M | 2.05% |
Jan 30, 2023 | 164.28M | -3.31% |
Jan 27, 2023 | 169.91M | -0.98% |
Jan 26, 2023 | 171.60M | 0.99% |
Jan 25, 2023 | 169.91M | 0.17% |
Jan 24, 2023 | 169.63M | 0.75% |
Jan 23, 2023 | 168.36M | 1.27% |
Jan 20, 2023 | 166.25M | 2.96% |
Jan 19, 2023 | 161.47M | 0.70% |
Jan 18, 2023 | 160.34M | -1.89% |
Jan 17, 2023 | 163.44M | -2.02% |
Jan 13, 2023 | 166.81M | 0.85% |
Jan 12, 2023 | 165.41M | 2.98% |
Jan 11, 2023 | 160.63M | 1.96% |
Jan 10, 2023 | 157.53M | 2.00% |
Jan 9, 2023 | 154.44M | -3.00% |
Jan 6, 2023 | 159.22M | 0.89% |
Jan 5, 2023 | 157.81M | -0.71% |
Jan 4, 2023 | 158.94M | 0.53% |
Jan 3, 2023 | 158.09M | -0.35% |
Dec 30, 2022 | 158.66M | 5.22% |
View and export this data all the way back to 2021.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Altimmune, Inc. | 745.25M |
Sutro Biopharma, Inc. | 408.65M |
G1 Therapeutics, Inc. | 400.34M |
PepGen Inc. | 363.46M |
Semler Scientific Inc. | 261.97M |
XOMA Corporation | 235.54M |
Singular Genomics Systems, Inc. | 210.62M |
Kamada Ltd. | 210.11M |
Nuvectis Pharma, Inc. | 151.92M |
Jounce Therapeutics, Inc. | 62.55M |